Ketamine for OCD: What the Evidence Shows

· Updated November 2026 · Aazaz Haq, MD

OCD

People with OCD who have not improved with medication and therapy sometimes ask whether ketamine could help. The honest answer is that it might, for some people, but the evidence is early. Here is what we know.

The short answer

Ketamine may help some people with OCD, but the evidence is early and comes from small studies. Exposure therapy and serotonin medications come first, and TMS for OCD has stronger evidence and FDA clearance. Ketamine is most often worth considering when OCD comes with depression that has not responded to treatment.

Standard treatment comes first

The best-established treatments for OCD are exposure and response prevention, a specific form of cognitive behavioral therapy, and serotonin medications such as SSRIs or clomipramine, often at higher doses and for longer than in depression. Many people improve with these, though often partly.

When they have not helped enough, TMS for OCD is the next step with the strongest evidence. It is FDA-cleared for OCD, and a large randomized trial in 2019 found it reduced symptoms more than a sham treatment. Our guide TMS for OCD explains how it works.

What the ketamine research shows

The best-known study, published in 2013, gave 15 adults with OCD either a single ketamine infusion or a placebo infusion. About half of those who received ketamine met criteria for a meaningful response one week later. Other small studies have been mixed, and the benefit, when it happens, can fade without further treatment.

So ketamine for OCD is promising but not proven. There are no large trials, and it is not FDA-approved for OCD.

Where ketamine can fit

In my practice, ketamine is most often considered for someone with OCD who also has significant depression that has not responded to treatment. Depression and OCD frequently occur together, and treating the depression can make it easier to do the hard work of therapy.

At McLean NTC we provide ketamine by IV infusion or intramuscular (IM) injection, always in a monitored setting. Your clinician will help you choose the route that suits you, and we coordinate with your therapist so the two treatments support each other.

What to expect if you try it

  • A full psychiatric evaluation first, including a review of what you have tried and how well.
  • Monitoring during each session for dissociation, nausea and blood pressure changes.
  • Regular measurement of OCD and depression symptoms, so we know whether it is helping.
  • Continued therapy. Ketamine is not a replacement for exposure work.

Ketamine for OCD is self-pay. TMS for OCD is covered by some insurance plans, and our team can check yours.

If OCD has not improved enough with standard treatment, request a consultation call to talk through the options.

Questions I hear often

Will ketamine make exposure therapy easier?

Possibly. Some people find they can engage more readily in exposure work in the days after treatment, when anxiety and depressive heaviness ease. This has not been studied rigorously, so I present it as a possibility, not a promise.

How fast would I know if it helps?

In the 2013 study, benefit appeared within hours to days. If there is no change after several treatments, it is reasonable to stop and consider other options.

Can I combine ketamine with TMS for OCD?

In some cases, yes, but we usually start one treatment at a time so we can tell what is helping.

How TMS for OCD works

Because TMS for OCD has stronger evidence, it is worth knowing more about. In the main trial, about 4 in 10 people responded to active treatment, compared with about 1 in 10 on a placebo treatment. Each session begins with a brief, personalized exposure to an OCD trigger, followed by stimulation of brain regions involved in the OCD loop. A course is about 29 sessions over six weeks. Like TMS for depression, it needs no anesthesia, and you drive yourself home. We use a coil designed for these deeper targets.

OCD is a condition where people often suffer quietly for years. If standard treatment has not helped enough, there are real options worth exploring.

References

  1. Rodriguez CI, et al. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology. 2013. PubMed
  2. Carmi L, et al. Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial. Am J Psychiatry. 2019. PubMed

Ready to take the next step?

Nothing here commits you to treatment. Start with a free consultation call with our patient advocate, who calls you back within one business day.

Or call us(571) 378-13986849 Old Dominion Drive, Suite 315, McLean
Call (571) 378-1398Request a consultation call